Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
    • 指導教授
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 醫學院
  3. 醫學檢驗暨生物技術學系
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/64670
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor楊雅倩
dc.contributor.authorWei-Chen Loen
dc.contributor.author駱威辰zh_TW
dc.date.accessioned2021-06-16T22:57:09Z-
dc.date.available2022-12-31
dc.date.copyright2012-09-18
dc.date.issued2012
dc.date.submitted2012-08-09
dc.identifier.citation1. http://www.doh.gov.tw/CHT2006/index_populace.aspx.
2. Kitisin, K. and L. Mishra, Molecular biology of colorectal cancer: new targets. Semin Oncol, 2006. 33(6 Suppl 11): p. S14-23.
3. Soreide, K., et al., Microsatellite instability in colorectal cancer. Br J Surg, 2006. 93(4): p. 395-406.
4. Walther, A., et al., Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer, 2009. 9(7): p. 489-99.
5. Le Beau, M.M., et al., An FHIT tumor suppressor gene? Genes Chromosomes Cancer, 1998. 21(4): p. 281-9.
6. Fodde, R. and R. Smits, Cancer biology. A matter of dosage. Science, 2002. 298(5594): p. 761-3.
7. Payne, S.R. and C.J. Kemp, Tumor suppressor genetics. Carcinogenesis, 2005. 26(12): p. 2031-45.
8. Kinzler, K.W. and B. Vogelstein, Cancer-susceptibility genes. Gatekeepers and caretakers. Nature, 1997. 386(6627): p. 761, 763.
9. Vogelstein, B. and K.W. Kinzler, Cancer genes and the pathways they control. Nature Medicine, 2004. 10(8): p. 789-799.
10. Buetow, K.H., et al., Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Proc Natl Acad Sci U S A, 1989. 86(22): p. 8852-6.
11. Yeh, S.H., et al., Allelic loss on chromosomes 4q and 16q in hepatocellular carcinoma: association with elevated alpha-fetoprotein production. Gastroenterology, 1996. 110(1): p. 184-92.
12. Chou, Y.H., et al., Frequent allelic loss on chromosomes 4q and 16q associated with human hepatocellular carcinoma in Taiwan. Cancer Lett, 1998. 123(1): p. 1-6.
13. Nagai, H., et al., Comprehensive allelotyping of human hepatocellular carcinoma. Oncogene, 1997. 14(24): p. 2927-33.
14. Shah, S.I., et al., Two distinct regions of loss on chromosome arm 4q in primary head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg, 2000. 126(9): p. 1073-6.
15. Shivapurkar, N., et al., Multiple regions of chromosome 4 demonstrating allelic losses in breast carcinomas. Cancer Res, 1999. 59(15): p. 3576-80.
16. Shivapurkar, N., et al., Deletions of chromosome 4 occur early during the pathogenesis of colorectal carcinoma. Hum Pathol, 2001. 32(2): p. 169-77.
17. Aikawa, J., et al., Multiple isozymes of heparan sulfate/heparin GlcNAc N-deacetylase/GlcN N-sulfotransferase. Structure and activity of the fourth member, NDST4. J Biol Chem, 2001. 276(8): p. 5876-82.
18. Yayon, A., et al., Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell, 1991. 64(4): p. 841-8.
19. Turnbull, J.E., et al., Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate. J Biol Chem, 1992. 267(15): p. 10337-41.
20. Ono, K., et al., Structural features in heparin that interact with VEGF(165) and modulate its biological activity. Glycobiology, 1999. 9(7): p. 705-711.
21. Esko, J.D. and S.B. Selleck, Order out of chaos: Assembly of ligand binding sites in heparan sulfate. Annual Review of Biochemistry, 2002. 71: p. 435-471.
22. Orellana, A., et al., Molecular cloning and expression of a glycosaminoglycan N-acetylglucosaminyl N-deacetylase/N-sulfotransferase from a heparin-producing cell line. J Biol Chem, 1994. 269(3): p. 2270-6.
23. Lin, X., et al., Heparan sulfate proteoglycans are essential for FGF receptor signaling during Drosophila embryonic development. Development, 1999. 126(17): p. 3715-23.
24. Lin, X. and N. Perrimon, Dally cooperates with Drosophila Frizzled 2 to transduce Wingless signalling. Nature, 1999. 400(6741): p. 281-4.
25. Toyoda, H., et al., Structural analysis of glycosaminoglycans in animals bearing mutations in sugarless, sulfateless, and tout-velu. Drosophila homologues of vertebrate genes encoding glycosaminoglycan biosynthetic enzymes. J Biol Chem, 2000. 275(29): p. 21856-61.
26. Fan, G., et al., Targeted disruption of NDST-1 gene leads to pulmonary hypoplasia and neonatal respiratory distress in mice. FEBS Lett, 2000. 467(1): p. 7-11.
27. Ringvall, M., et al., Defective heparan sulfate biosynthesis and neonatal lethality in mice lacking N-deacetylase/N-sulfotransferase-1. J Biol Chem, 2000. 275(34): p. 25926-30.
28. Forsberg, E., et al., Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme. Nature, 1999. 400(6746): p. 773-6.
29. Humphries, D.E., et al., Heparin is essential for the storage of specific granule proteases in mast cells. Nature, 1999. 400(6746): p. 769-772.
30. Pallerla, S.R., et al., Altered heparan sulfate structure in mice with deleted NDST3 gene function (vol 283, pg 16885, 2008). Journal of Biological Chemistry, 2008. 283(33): p. 22884-22884.
31. Iozzo, R.V., Heparan sulfate proteoglycans: intricate molecules with intriguing functions. J Clin Invest, 2001. 108(2): p. 165-7.
32. Vlodavsky, I., et al., Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism? Trends Biochem Sci, 1991. 16(7): p. 268-71.
33. Pallerla, S.R., et al., Altered heparan sulfate structure in mice with deleted NDST3 gene function. J Biol Chem, 2008. 283(24): p. 16885-94.
34. Logan, C.Y. and R. Nusse, The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol, 2004. 20: p. 781-810.
35. Pinto, D. and H. Clevers, Wnt, stem cells and cancer in the intestine. Biol Cell, 2005. 97(3): p. 185-96.
36. Scoville, D.H., et al., Current view: intestinal stem cells and signaling. Gastroenterology, 2008. 134(3): p. 849-64.
37. Tsuda, M., et al., The cell-surface proteoglycan Dally regulates Wingless signalling in Drosophila. Nature, 1999. 400(6741): p. 276-80.
38. Korinek, V., et al., Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet, 1998. 19(4): p. 379-83.
39. Pinto, D., et al., Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes Dev, 2003. 17(14): p. 1709-13.
40. Ireland, H., et al., Inducible Cre-mediated control of gene expression in the murine gastrointestinal tract: effect of loss of beta-catenin. Gastroenterology, 2004. 126(5): p. 1236-46.
41. Van der Sluis, M., et al., Muc2-deficient mice spontaneously develop colitis, indicating that Muc2 is critical for colonic protection. Gastroenterology, 2006. 131(1): p. 117-129.
42. Velcich, A., et al., Colorectal cancer in mice genetically deficient in the mucin Muc2. Science, 2002. 295(5560): p. 1726-1729.
43. Crosnier, C., D. Stamataki, and J. Lewis, Organizing cell renewal in the intestine: stem cells, signals and combinatorial control. Nature Reviews Genetics, 2006. 7(5): p. 349-359.
44. Qiao, L. and B.C. Wong, Role of Notch signaling in colorectal cancer. Carcinogenesis, 2009. 30(12): p. 1979-86.
45. Zecchini, V., et al., Notch signaling regulates the differentiation of post-mitotic intestinal epithelial cells. Genes Dev, 2005. 19(14): p. 1686-91.
46. Staal, F.J. and A.W. Langerak, Signaling pathways involved in the development of T-cell acute lymphoblastic leukemia. Haematologica, 2008. 93(4): p. 493-7.
47. Milano, J., et al., Modulation of notch processing by gamma-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation. Toxicological Sciences, 2004. 82(1): p. 341-358.
48. Barten, D.M., et al., Gamma-secretase inhibitors for Alzheimer's disease: balancing efficacy and toxicity. Drugs R D, 2006. 7(2): p. 87-97.
49. Chen, G., et al., SPDEF is required for mouse pulmonary goblet cell differentiation and regulates a network of genes associated with mucus production. Journal of Clinical Investigation, 2009. 119(10): p. 2914-2924.
50. Noah, T.K., B. Donahue, and N.F. Shroyer, Intestinal development and differentiation. Exp Cell Res, 2011. 317(19): p. 2702-10.
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/64670-
dc.description.abstract大腸直腸癌生成主要是由於基因變異的累積所造成,如致癌基因的活化和抑癌基因的刪除。本實驗室先前的研究,在人類第四號染色體4q25-4q28.3區域篩選出NDST4於大腸直腸癌可能扮演抑癌基因的角色,為了研究NDST4的功能,實驗室製造Ndst4基因剔除小鼠。本論文主要分為兩個研究,第一部分於Ndst4基因剔除鼠,研究其表現型的變化,以探討此基因於小鼠可能的生理功能。首先,利用多重聚合酶鏈鎖反應(multiplex PCR)和南方墨點法確認Ndst4基因剔除小鼠的基因型,再以反轉錄聚合酶鏈鎖反應確認Ndst4基因在野生型小鼠各器官的表現情況,並利用RNA表現量最高的器官(腦),確認Ndst4基因剔除鼠之RNA表現。利用全血球計數(complete blood count, CBC)、血清生化檢驗、modified-SHIRPA和組織切片檢查Ndst4基因剔除小鼠是否有表現型的變異。在modified-SHIRPA、CBC和血清生化檢驗的初步結果相較於野生型小鼠,Ndst4基因剔除小鼠並沒有看到顯著的差異,但在組織切片檢查,發現Ndst4基因剔除小鼠在近端大腸之杯狀細胞數量增加,且在小腸絨毛形態改變。論文第二部分是小鼠Ndst4抗血清的製作。首先利用CLC Sequence viewer 6分析軟體找出mNdst4蛋白質與mNdst家族其他成員(Ndst1-Ndst3)相似性最低的一段胺基酸序列,再將此段序列做B細胞抗原決定位(B cell epitope)的分析,最後決定以mNdst4第40-226個胺基酸序列做為抗原(mNdst4-N),利用E coli.表現目標蛋白並純化。再將純化mNdst4-N蛋白打入五隻Balb/C小鼠,最後以西方墨點法檢測小鼠血清中,anti-mNdst4-N抗體的效價與專一性。結果得知:五隻小鼠之抗血清皆能辨認mNdst4抗原且一號和三號小鼠能與人類NDST4 (hNDST4)產生交叉反應。從目前結果預期:未來能應用於mNdst4和hNDST4專一性之單株抗體的製作,並幫助爾後此蛋白生理功能之研究。zh_TW
dc.description.abstractThe development of colorectal cancer originates from accumulation of many genetic defects, including activation of oncogenes and deletion of tumor suppressor genes. Our previous study found a putative tumor suppressor gene, NDST4, at chromosome 4q26 in colorectal cancer. So, we produced a Ndst4 knock out (Ndst4 KO) mouse to study the probable physiological functions of NDST4. In this thesis, there are two parts of investigation. First, we want to examine whether there are phenotype differences between Ndst4 KO and wild type (WT) mice. In this part, we used Southern blotting and multiplex PCR to identify the genotype of Ndst4 KO mice. Then, we used RT-PCR to check the tissue spectrum of Ndst4 RNA expression. We used the organ (Brain) with higher RNA expression to confirm that Ndst4 KO mice have no Ndst4 RNA expression. Finally, we conducted the modified-SHIRPA, complete blood count (CBC), biochemistry and histology analyses to compare Ndst4 KO and WT mice. In the modified-SHIRPA, CBC and biochemistry, we did not get significantly different results. However, in the histology analysis, we found that there were more goblet cells in proximal colon, and small intestine had morphological change in Ndst4 KO mice. Second, we want to produce mouse Ndst4 antisera. Because Ndst family has four members that have high similarity in protein sequences. So, we aligned all of the Ndst protein sequences by CLC sequence view 6 software, and found out a region with lower similarity. Then, we selected the sequences selected to perform B-epitope prediction. According to the information obtained, we decide to use 40 to 226 amino acids as immunogen. We used E coli system to express the target protein, and then performed protein purification. Finally, we used Balb/C mice to perform antigen immunization, and used Western blotting to determine titers and specificity of mouse antisera. All of the mouse antisera could recognize mouse Ndst4 antigen. In addition, 2 mouse antisera also could recognize human NDST4 (hNDST4) antigen. At present, we have got mouse antisera against mNdst4 and hNDST4 that could be applied at NDST4-associated study in the future.en
dc.description.provenanceMade available in DSpace on 2021-06-16T22:57:09Z (GMT). No. of bitstreams: 1
ntu-101-R99424029-1.pdf: 11085191 bytes, checksum: c296c3fc52be579ef5fcdca6f4109d87 (MD5)
Previous issue date: 2012
en
dc.description.tableofcontents致謝 i
摘要 ii
Abstract iii
縮寫對照表 v
圖目錄 ix
表目錄 x
一、緒論 1
1、研究背景 1
1.1、大腸直腸癌 1
1.2、腫瘤抑制基因(tumor suppressor gene) 1
2、相關文獻回顧 2
2.1、第四號染色體基因刪除 2
2.2、NDST(N-deacetylase/ N-sulfotransferase)家族與NDST4 3
3、實驗室先前研究結果 4
3.1、染色體四號之失異型性檢測 4
3.2、Ndst4基因剔除小鼠 4
二、研究目標 6
三、材料與方法 7
1、基因轉殖鼠基因型分析 7
1.1、DNA萃取 7
1.2、多重PCR (multiplex PCR) 7
1.3、南方墨點法(southern blot) 7
2、RNA檢測 9
2.1、RNA萃取 9
2.2、合成cDNA 9
2.3、聚合酶鏈鎖反應(polymerase chain reaction, PCR) 10
3、Ndst4基因剔除小鼠表現型分析 10
3.1、modified-SHIRPA檢測 10
3.2、血液檢測 10
3.3、生化檢測 11
4、病理組織處理及染色 11
4.1、病理組織處理 11
4.2、蘇木紫-伊紅染色 (Hematoxylin & Eosin stain) 11
4.3、免疫組織化學染色 (Immunohistochemistry stain) 12
4.4、阿爾斯藍染色(Alcian blue staining) 12
4.5、希夫氏染色(Periodic Acid Schiff Staining) 13
5、蛋白質純化 13
6、蛋白質檢測 13
6.1、SDS-PAGE 13
6.2、西方墨點法(western blot) 14
7、統計分析 14
四、實驗結果 15
1、Ndst4基因剔除小鼠基因型分析 15
2、Ndst4基因剔除小鼠的RNA表現分析 15
3、Ndst4基因剔除小鼠表現型分析 16
3.1、血液檢測 16
3.2、生化檢測 17
3.3、modified-SHIRPA檢測 17
3.4、組織切片檢測 17
4、Mouse Ndst4單株抗體製備 18
4.1、蛋白質表現質體構築 18
4.2、蛋白質誘導條件測試 19
4.3、蛋白質純化 19
4.4、抗血清效價(titer)測定 19
4.5、抗血清專一性測試(Mouse) 20
4.6、小鼠內生性抗原測試 20
4.7、抗血清專一性測試(Human) 21
五、討論 22
六、圖 25
七、表 53
八、參考文獻 59
九、附表 65
十、附錄 68
dc.language.isozh-TW
dc.subject大腸直腸癌zh_TW
dc.subjectNDST4zh_TW
dc.subject基因剔除鼠zh_TW
dc.subject表現型zh_TW
dc.subject單株抗體zh_TW
dc.subjectColorectal canceren
dc.subjectNDST4en
dc.subjectKnock out miceen
dc.subjectPhenotypeen
dc.subjectmonoclonal antibodyen
dc.titleNdst4基因剔除鼠之表現型分析暨小鼠Ndst4抗血清製備zh_TW
dc.titlePhenotype analysis of Ndst4 knockout mice and preparation of mouse Ndst4 antiseraen
dc.typeThesis
dc.date.schoolyear100-2
dc.description.degree碩士
dc.contributor.oralexamcommittee蔡錦華,林淑華
dc.subject.keyword大腸直腸癌,NDST4,基因剔除鼠,表現型,單株抗體,zh_TW
dc.subject.keywordColorectal cancer,NDST4,Knock out mice,Phenotype,monoclonal antibody,en
dc.relation.page72
dc.rights.note有償授權
dc.date.accepted2012-08-09
dc.contributor.author-college醫學院zh_TW
dc.contributor.author-dept醫學檢驗暨生物技術學研究所zh_TW
顯示於系所單位:醫學檢驗暨生物技術學系

文件中的檔案:
檔案 大小格式 
ntu-101-1.pdf
  未授權公開取用
10.83 MBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved